Category: Impacting News
Market Frustration, Volatility and Chaos
Stock Market Fluctuations and Volatility Only history can remind us that what’s going on recently with the stock market is not new. Similar situations have taken place during the terms of every president since Ronald Reagan. Indeed, the same stock...
Read More
March 12, 2020
0
A Market in Chaos. Moderna's Human Trial Began Today
A Market in Chaos The Market is in chaos. When this happens the market needs to be stopped from causing massive unwarranted harm to countries' economies, the firms and investors in the stock market. A healthy market does not drop...
Read More
March 16, 2020
0
A Biotech Firm We Love to Discover
Rubius Therapeutics Finding small development-stage biotech firms that contribute to biotechnology's limitless revolution of the biological sciences is difficult, but indispensable. Falling on firms that might have the science, the technological capability and the inspiration towards creating new diagnostics and...
Read More
March 30, 2021
0
Important News and Results from Two Companies in the Prohost Portfolio
Important News and Results from Akero Therapeutics Akero Therapeutics ( AKRO ) announced that full results of the main portion of its Phase 2a BALANCED trial in biopsy-confirmed NASH patients with F1-F3 fibrosis have been published in Nature Medicine. The study...
Read More
July 9, 2021
0
Exelixis CABOMETYX: Now Approved in Europe for First-Line Treatment of Renal Cell Carcinoma
Exelixis Boxed in on Good News Exelixis ( EXEL ) is one of the firms boxed in by rule of thumb traders and short-sellers who put enormous pressure on biotech firms regardless of their good news. We sincerely believe that...
Read More
April 1, 2021
0
We Introduce UroGen Pharma and Discuss Its Pipeline of Products
Presenting UroGen Pharma UroGen Pharma ( URGN ) focuses on cancers and urologic diseases. It announced its fourth quarter and full-year ended December 31, 2019 financial results. The announcement started with Liz Barrett, President and Chief Executive Officer (CEO) of UroGen...
Read More
April 2, 2020
0
Intellia Therapeutics Announces More Good News
Intellia Therapeutics NTLA-2001 for ATTR Granted Orphan Drug Designation by the EC Intellia Therapeutics ( NTLA ) announced that the European Commission (EC) has granted its product NTLA-2001 orphan drug designation. The investigational product is being developed as a treatment for transthyretin...
Read More
April 5, 2021
0
The Time Has Come for Us To Present Fate Therapeutics
Presenting Fate Therapeutics Today we are presenting Fate Therapeutics ( FATE ); a clinical-stage company developing programmed cellular immunotherapies for cancer and immune disorders. Our enthusiasm for this firm is due to its announcement that it signed a global collaboration...
Read More
April 3, 2020
0
Novavax: A Hand-Picked Vaccine on the Road Towards Human Clinical Trial Against Coronavirus
Novavax Identified an "Ideal" Coronavirus Vaccine Candidate The news from Novavax ( NVAX ) informs that the firm has identified an "ideal" coronavirus vaccine candidate, NVX-CoV2373 , that is a stable, prefusion protein made using Novavax’s proprietary nanoparticle technology. The...
Read More
April 8, 2020
0
Cassava Sciences Stock Soared. See Also: The Resurrection of Sunesis Pharmaceuticals
Cassava Sciences Soared Cassava Sciences ( SAVA ) stock soared today. The firm announced that it will present two new clinical datasets for its product candidates at the 2021 Alzheimer’s Association International Conference ( AAIC ), which will be held virtually in Denver,...
Read More
July 21, 2021
0
Search ProhostBiotech
Popular Links
23andMe Holding Co (ME)Abbott Laboratories (ABT)AbbVie Inc (ABBV)AbCelleraAbeona Therapeutics (ABEO)Ablynx (ABLX)AbVitro IncAcadia (ACAD)Acceleron Pharma (XLRN)AcelRx Pharmaceuticals (ACRX).Acorda Therapeutics Inc (ACOR)Acumen Pharmaceuticals (ABOS)AdaptImmune Therapeutics (ADAP)Adaptive BiotechnologiesADC Therapeutics (ADCT)Adimab LLCAdvanced Micro Devices (AMD)Advaxis (ADXS)Adverum Biotechnologies (ADVM)Aerie Pharmaceuticals (AERI)AgenTus TherapeuticsAgenus (AGEN)AgeX Therapeutics (AGE)Agilent Technologies (A)Agilis Biotherapeutics IncAgios Pharmaceuticals (AGIO)AIM ImmunoTech (AIM)Aimmune Therapeutics (AIMT)Akari Therapeutics (AKTX)Akashi TherapeuticsAkcea Therapeutics (AKCA)Akebia Therapeutics Inc (AKBA)Akero Therapeutics (AKRO)Akous Inc (a wholly owned subsidiary of Eli Lilly Company)Alder BioPharmaceuticals (ALDR)Alexion Pharmaceuticals (ALXN)Alkermes (ALKS)Allergan Plc (AGN)Allogene TherapeuticsAllogene Therapeutics (ALLO)